MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Unilateral Hypertrophic Olivary Degeneration in Anti-GAD-associated Encephalomyelitis

O. Turgunkhujaev, YU. Seliverstov, V. Fominykh, L. Brylev (Moscow, Russian Federation)

Meeting: 2022 International Congress

Abstract Number: 72

Keywords: Glutamic acid decarboxylase, Guillain-Mollaret triangle, Palatal tremor(see Tremors)

Category: Neuroimaging (Non-PD)

Objective: We present a patient with GAD65-Ab-related encephalomyelitis who developed unilateral hypertrophic olivary degeneration (HOD) in the absence of structural lesions within the Guillain-Mollaret triangle.

Background: Neuroimaging in syndromes associated with GAD65-Ab are usually either unremarkable or can show mesial temporal lobe T2-hyperintensities; in the cases of long-term predominant ataxia, cerebellar atrophy can be found [1].

Method: A 55-year-old woman presented with stiffness of axial muscles, cerebellar syndrome, oculomotor abnormalities, and palatal tremor. At 32, she developed progressive stiffness in the abdomen muscles and episodic falls. At 43, she started experiencing episodic stiffening of the right leg, painful nocturnal muscle spasms, gait impairment, and diplopia. At 49, she was diagnosed with stiff person syndrome based on high serum GAD65-Ab titer (> 2000 U/mL) and continuous paraspinal muscle activity on EMG. Brain MRI was unremarkable. Clonazepam provided modest improvement; she refused oral steroids. At 53, 1st session of plasma exchange (PE) with a good clinical response for one year. She then started to use a walker and developed a skew deviation. Repeated PE led to no benefits. In March 2020, she received 3 g of IV methylprednisolone and 2 g/kg of IVIG, with improvement in eye movements, muscle stiffness, and gait. In August 2020, muscle stiffness and cerebellar ataxia worsened (patient lost ability to ambulate), and mild palatal tremor was found. Repeated 1.5T brain MRI showed left HOD with no lesions within the dentato-rubro-olivary pathway (Figure 1 C,D).

Results: Palatal tremor is a known rare symptom of the GAD65-Ab-related conditions [2], and HOD was not reported until recently [3,4]. In our patient, 1.5T brain MRI showed no brainstem lesions, suggesting functional chemical denervation as a possible cause of the unilateral HOD. Another explanation may be resolution limitations of a 1.5T MRI, as it was the case where 7T brain MRI allowed to identify only one causal lesion in a patient with bilateral HOD due to GAD65-Ab, and authors suggested that chemical denervation accounted for the hypertrophic degeneration of another inferior olive [3].

Conclusion: HOD may develop not only due to organic but also due to the functional disruption of the dentato-rubro-olivary pathways. GAD65-Ab-related neurologic disorders should be considered in the differential diagnosis in patients with HOD.

photo 2022-03-12 22-18-21

References: [1] Dade M, Berzero G, Izquierdo C, Giry M, Benazra M, Delattre J-Y, et al. Neurological Syndromes Associated with Anti-GAD Antibodies. Int J Mol Sci 2020;21:3701. https://doi.org/10.3390/ijms21103701.
[2] Nemni R, Braghi S, Natali-Sora MG, Lampasona V, Bonifacio E, Comi G, et al. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 1994;36:665–7. https://doi.org/10.1002/ana.410360419.
[3] Macaron G, Willis MA, Ontaneda D, Fernandez H, Kim S, Jones SE, et al. Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder. Neurology 2020;94:273–5. https://doi.org/10.1212/WNL.0000000000008926.
[4] Ip M, Li S, Wai T, Wong L. Oculopalatal tremor (OPT) in a patient with anti-GAD brainstem encephalitis: A case report [abstract]. Mov Disord 2019;34 (suppl.)

To cite this abstract in AMA style:

O. Turgunkhujaev, YU. Seliverstov, V. Fominykh, L. Brylev. Unilateral Hypertrophic Olivary Degeneration in Anti-GAD-associated Encephalomyelitis [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/unilateral-hypertrophic-olivary-degeneration-in-anti-gad-associated-encephalomyelitis/. Accessed July 9, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/unilateral-hypertrophic-olivary-degeneration-in-anti-gad-associated-encephalomyelitis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley